Epidermology of tb and investigation psm k park detail easy language

Reading File
Now let me search the medical library for TB epidemiology and investigation from Park's PSM textbook.
Finding Sources
Finding Sources
Park's PSM is available. Let me search specifically within it for TB content.
Finding Sources
The main TB content is in block3. Let me read the core sections on epidemiology and investigation.
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Now let me get the epidemiology section - host, agent, environment factors:
Reading File
I now have sufficient content from Park's PSM to give a comprehensive, well-organized answer. Let me compile everything.

Tuberculosis (TB) - Epidemiology & Investigations

As per Park's Textbook of Preventive and Social Medicine


1. WHAT IS TB?

TB is a specific infectious disease caused by Mycobacterium tuberculosis. It mainly affects the lungs (pulmonary TB), but can also affect:
  • Intestine
  • Meninges (brain covering)
  • Bones and joints
  • Lymph glands
  • Skin
Bovine TB (from cattle) can also be transmitted to humans.

2. GLOBAL BURDEN (Problem Statement)

FactDetail
Population infected (silent)~1/3rd of world population asymptomatically infected
Who develops disease5-10% of infected develop clinical TB in their lifetime
New cases/year (2019)~10 million globally
Annual infection risk in high burden countries0.5-2%
One patient spreads to10-15 persons per year
TB deaths (HIV-negative, 2019)1.2 million
TB deaths (HIV-positive, 2019)208,000
Gender splitMen 56%, Women 32%, Children <15 yrs 12%

3. INDIA'S TB BURDEN

  • India has the highest TB burden in the world.
  • 2/3 of cases are males, but >50% of female cases occur in those below 34 years of age.
  • TB kills more women in reproductive age than all maternal causes combined.
  • 1/3 of female infertility in India is caused by TB.
  • ~3 lakh children of TB patients drop out of school.
  • A patient loses 3-4 months of income during recuperation.
  • 90% of TB's economic burden = loss of life, not just illness.
  • Mainly a disease of the poor: migrant labourers, slum dwellers, and backward areas.

4. EPIDEMIOLOGICAL INDICES (How We Measure TB in a Community)

These are important Park's PSM exam points:
IndexMeaning
IncidenceNew + recurrent (relapse) TB episodes in a given year
PrevalenceTotal TB cases (all forms) at a given point in time; best index for case load
MortalityDeaths due to TB (HIV-negative counted separately from HIV-positive per ICD-10)
Case Fatality RateRisk of death among those with active TB
Case Notification RateNew + recurrent TB cases notified to WHO per 100,000 population per year
Case Detection RateNotifications of new+relapse cases ÷ Estimated incidence × 100

5. CLASSIFICATION OF TB CASES

A. Based on Drug Susceptibility (Drug Resistance)

TypeDefinition
Mono-resistanceResistant to ONE first-line drug only
Polydrug resistanceResistant to >1 first-line drug (but NOT both INH + Rifampicin together)
MDR-TBResistant to at least BOTH Isoniazid (INH) and Rifampicin
XDR-TBMDR + resistant to any fluoroquinolone + at least one second-line injectable (kanamycin, amikacin, capreomycin)
Rifampicin Resistance (RR-TB)Resistance to Rifampicin by any method (includes MDR + XDR)

B. Based on HIV Status

  • HIV-positive TB
  • HIV-negative TB
  • HIV-unknown TB

6. INVESTIGATIONS FOR TB (Case Finding)

A. Sputum Smear Microscopy (Most Important - Primary Method)

  • Sputum examination by direct microscopy = Method of Choice for field diagnosis
  • Stains used:
    • ZN (Ziehl-Neelsen) stain - conventional microscope
    • LED FM (Fluorescent Microscopy) - more sensitive
  • Why it's #1: Cheap, reliable, easy, discovers the most epidemiologically dangerous cases (sputum-positive = biggest spreaders)
  • Limitation: Limited sensitivity, especially in children and HIV-positive patients

B. Culture

MethodDetail
Solid culture (LJ medium)Gold standard but takes 6-8 weeks
Liquid culture (MGIT-960, BacT Alert, Versatrek)Faster; results in up to 42 days
Drug Sensitivity Testing (DST)Available 14-26 days after culture turns positive
  • Used for:
    • Follow-up of DR-TB patients
    • Long-term follow-up of DS-TB to ensure relapse-free cure

C. Rapid Molecular Tests

TestWhat it detects
CBNAAT / TrueNat (NAAT)MTB + Rifampicin resistance (rpoB gene)
Line Probe Assay (LPA) - FL LPAMTB complex + RIF & INH resistance
Line Probe Assay - SL LPAFluoroquinolone + Second-line injectable resistance
PCR-based methodsrpoB (Rifampicin), katG + inhA (Isoniazid) resistance genes

D. Tuberculin Skin Test (TST / Mantoux Test)

  • Detects cellular immune response to TB proteins (PPD)
  • Read at 48-72 hours after injection
  • Positive = presence of infection (NOT necessarily active disease)
  • Limitations (important for exams):
    • Negative test does NOT rule out TB (immune response may be depressed in active TB)
    • False negatives: HIV, malnutrition, malignancy, Hodgkin's, measles, chickenpox, steroids, severe bacterial infections, BCG recently given
    • False positives: BCG vaccination, atypical mycobacteria cross-reaction
Two-Step Testing (for health workers):
  • 1st test → if negative → 2nd test after 1-3 weeks → if 2nd positive = old infection (boosted), if 2nd negative = truly uninfected

E. Interferon Gamma Release Assay (IGRA)

  • Blood test, more specific than TST
  • Not affected by BCG vaccination
  • Used as supportive diagnostic tool

F. Supportive/Radiological Tools

  • Chest X-ray - shows cavitation, infiltrates, hilar adenopathy (supportive, not confirmatory)
  • Histopathology - caseous granuloma with Langhans giant cells (tissue biopsy)

7. QUICK MEMORY TABLE: Investigations at a Glance

TestUseKey Point
Sputum Smear (ZN stain)Primary case findingCheap, fast, most used
Culture (LJ/MGIT)Confirmation + DSTTakes weeks
CBNAAT/TrueNatRapid diagnosis + Rif resistanceDone in 2 hours
LPA (FL/SL)First/second-line drug resistanceFor MDR/XDR-TB
Mantoux/TSTInfection screenDoes NOT confirm active TB
IGRAInfection screenMore specific than TST
Chest X-raySupportiveNot confirmatory

8. TB PREVENTIVE TREATMENT (2019 Data)

  • 45% of HIV-positive newly enrolled patients received preventive treatment
  • 33% of children under 5 (household contacts of confirmed TB) received preventive treatment

Source: Park's Textbook of Preventive and Social Medicine, 25th edition - Chapter on Tuberculosis (Epidemiology, Investigations, RNTCP/NTEP)

Exam Tips (PSM perspective):
  • Sputum smear = method of choice for case finding in the field
  • Prevalence = best practical index for case load
  • 1/3 of world infected, 5-10% develop disease
  • One infectious patient spreads to 10-15 persons/year
  • MDR = INH + Rifampicin resistance (minimum)
  • Negative Mantoux does NOT rule out TB (immunosuppression causes false negatives)
This is a shared conversation. Sign in to Orris to start your own chat.